SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-23-008825
Filing Date
2023-03-03
Accepted
2023-03-03 17:30:09
Documents
1
Period of Report
2023-03-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 5614
  Complete submission text file 0001127602-23-008825.txt   7243
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Issuer) CIK: 0001830214 (see all company filings)

IRS No.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SOARING EAGLE ACQUISITION CORP. 955 FIFTH AVENUE NEW YORK NY 10075
Business Address
Dmytruk Mark E. (Reporting) CIK: 0001873507 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40097 | Film No.: 23706039